Zhang T, Zhang Y, Leng X. Global, regional, and national trends in gastric cancer burden: 1990–2021 and projections to 2040. Front Oncol. 2024;14:1468488.
Google Scholar
Yang W-J, Zhao H-P, Yu Y, Wang J-H, Guo L, Liu J-Y, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29:2452–68.
Google Scholar
Li X, Xu J, Xie J, Yang W. Research progress in targeted therapy and immunotherapy for gastric cancer. Chin Med J. 2022;135:1299–313.
Google Scholar
Freire de Melo F, Marques HS, Rocha Pinheiro SL, Lemos FFB, Silva Luz M, Nayara Teixeira K, et al. Influence of Helicobacter pylori oncoprotein caga in gastric cancer: a critical-reflective analysis. World J Clin Oncol. 2022;13:866–79.
Google Scholar
Hatakeyama M. Impact of the Helicobacter pylori oncoprotein CagA in gastric carcinogenesis. Curr Top Microbiol Immunol. 2023;444:239–57.
Google Scholar
Buti L, Ruiz-Puig C, Sangberg D, Leissing TM, Brewer RC, Owen RP, et al. CagA–ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids. Proc Natl Acad Sci. 2020;117:2645–55.
Google Scholar
Lim NR, Chung WC. Helicobacter pylori-associated chronic atrophic gastritis and progression of gastric carcinogenesis. Korean J Gastroenterol. 2023;82:171–9.
Google Scholar
Yang Y, Meng W-J, Wang Z-Q. Cancer stem cells and the tumor microenvironment in gastric cancer. Front Oncol. 2022;11:803974.
Google Scholar
Fatehullah A, Terakado Y, Sagiraju S, Tan TL, Sheng T, Tan SH, et al. A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers. Nat Cell Biol. 2021;23:1299–313.
Google Scholar
Rao X, Zhang C, Luo H, Zhang J, Zhuang Z, Liang Z, et al. Targeting gastric cancer stem cells to enhance treatment response. Cells. 2022;11:2828.
Google Scholar
Yang L, Du Y, Liao F, Huang T, Liu Y, Liu J, et al. A novel combined therapeutic strategy of Nano-EN-IR@Lip mediated photothermal therapy and stem cell inhibition for gastric cancer. Biomed Pharmacother. 2024;174:116486.
Google Scholar
Muhammad JS, Eladl MA, Khoder G. Helicobacter pylori-induced DNA methylation as an epigenetic modulator of gastric cancer: recent outcomes and future direction. Pathogens. 2019;8:23.
Google Scholar
Cui X, Chang M, Wang Y, Liu J, Sun Z, Sun Q, et al. Helicobacter pylori reduces METTL14-mediated VAMP3 m6A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling. Cell Death Discov. 2025;11:13.
Google Scholar
Christodoulidis G, Koumarelas K-E, Kouliou M-N, Thodou E, Samara M. Gastric cancer in the era of epigenetics. Int J Mol Sci. 2024;25:3381.
Google Scholar
Song H, Yao X, Zheng Y, Zhou L. Helicobacter pylori infection induces POU5F1 upregulation and SPP1 activation to promote chemoresistance and T cell inactivation in gastric cancer cells. Biochem Pharmacol. 2024;225:116253.
Google Scholar
Fujii Y, Murata-Kamiya N, Hatakeyama M. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells. Cancer Sci. 2020;111:1596–606.
Google Scholar
Wang H, Zhao M, Shi F, Zheng S, Xiong L, Zheng L. A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. Front Cell Infect Microbiol. 2023;13:1062803.
Google Scholar
Takahashi-Kanemitsu A, Lu M, Knight CT, Yamamoto T, Hayashi T, Mii Y, et al. The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells. Sci Signal. 2023;16:eabp9020.
Google Scholar
Chen Z, Dong Z, Xiang H, Chen S, Yu W, Liang C. Helicobacter pylori CagA protein induces gastric cancer stem cell-like properties through the Akt/FOXO3a axis. J Cell Biochem. 2024;125:e30527.
Google Scholar
Woo HD, Fernández-Jiménez N, Ghantous A, Degli Esposti D, Cuenin C, Cahais V, et al. Genome-wide profiling of normal gastric mucosa identifies Helicobacter pylori- and cancer-associated DNA methylome changes. Int J Cancer. 2018;143:597–609.
Google Scholar
Zhang L, Li W, Cao L, Xu J, Qian Y, Chen H, et al. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53. Oncogene. 2019;38:4590–604.
Google Scholar
Chang X, Ma J, Xue X, Wang G, Yan T, Su L, et al. DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer. PeerJ. 2021;9:e12146.
Google Scholar
Cao D, Jia Z, Wu Y, Su T, Zhao D, Wu M, et al. Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice. Life Sci. 2020;263:118580.
Google Scholar
Zhou J, Shi J, Fu X, Mao B, Wang W, Li W, et al. Linc00441 interacts with DNMT1 to regulate RB1 gene methylation and expression in gastric cancer. Oncotarget. 2018;9:37471–9.
Google Scholar
Geng H, Cheng Z, Cao R, Wang Z, Xing S, Guo C, et al. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer. Oncol Rep. 2018;40:2778–87.
Google Scholar
Liu F, Huang W, Hong J, Cai C, Zhang W, Zhang J, et al. Long noncoding RNA LINC00630 promotes radio-resistance by regulating BEX1 gene methylation in colorectal cancer cells. IUBMB Life. 2020;72:1404–14.
Google Scholar
Norollahi SE, Mansour-Ghanaei F, Joukar F, Ghadarjani S, Mojtahedi K, Gharaei Nejad K, et al. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy. Biomed Pharmacother. 2019;115:108958.
Google Scholar
Exposito F, Redrado M, Serrano D, Calabuig-Fariñas S, Bao-Caamano A, Gallach S, et al. G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer drugs through SCARA5 and AOX1. Cell Death Dis. 2024;15:787.
Google Scholar
Uysal F, Sukur G, Bozdemir N, Cinar O. DNA methyltransferase (Dnmt) silencing causes increased Cdx2 and Nanog levels in surviving embryos. Int J Dev Biol. 2023;67:1–8.
Google Scholar
Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biol. 2019;20:245.
Google Scholar
Li N, Tang B, Jia Y, Zhu P, Zhuang Y, Fang Y, et al. Helicobacter pylori CagA protein negatively regulates autophagy and promotes inflammatory response via c-Met-PI3K/Akt-mTOR signaling pathway. Front Cell Infect Microbiol. 2017;7:417.
Google Scholar
Sakatani A, Hayashi Y, Saiki H, Kato M, Uema R, Inoue T, et al. A novel role for Helicobacter pylori cytotoxin-associated gene A in negative regulation of autophagy in human gastric cells. BMC Gastroenterol. 2023;23:326.
Google Scholar
Reyes-Leon A, Atherton JC, Argent RH, Puente JL, Torres J. Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA Gene. Infect Immun. 2007;75:3445–54.
Google Scholar
Li N, Feng Y, Hu Y, He C, Xie C, Ouyang Y, et al. Helicobacter pylori CagA promotes epithelial-mesenchymal transition in gastric carcinogenesis via triggering the oncogenic YAP pathway. J Exp Clin Cancer Res. 2018;37:280.
Google Scholar
Nascakova Z, He J, Papa G, Francas B, Azizi F, Müller A. Helicobacter pylori induces the expression of Lgr5 and stem cell properties in gastric target cells. Life Sci Alliance. 2024;7:e202402783.
Google Scholar
Guo K, Duan J, Lu J, Xiao L, Han L, Zeng S, et al. Tumor necrosis factor-α-inducing protein of Helicobacter pylori promotes epithelial-mesenchymal transition and cancer stem-like cells properties via activation of Wnt/β-catenin signaling pathway in gastric cancer cells. Pathog Dis. 2022;80:ftac025.
Google Scholar
Pandey S, Jha HC, Shukla SK, Shirley MK, Robertson ES. Epigenetic regulation of tumor suppressors by Helicobacter pylori enhances EBV-induced proliferation of gastric epithelial cells. mBio. 2018;9:e00649–18.
Google Scholar
Ohanna M, Cerezo M, Nottet N, Bille K, Didier R, Beranger G, et al. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype. Genes Dev. 2018;32:448–61.
Google Scholar
